ArticleProbiotics and antimicrobial proteins2026
Functional, Modeling and Antimicrobial Characterization of Lactobacillus helveticus BGRA43 Isolated from Traditional Iranian Cheese.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lactobacillus helveticus strains are recognized as promising dairy starter cultures and probiotics. This study aimed to isolate and characterize L. helveticus BGRA43 from traditional Iranian Khiki cheese and evaluate its functional and probiotic potential. The strain exhibited prominent β-galactosidase activity and fermented key milk sugars (lactose, galactose). It demonstrated robust tolerance to acidic pH and gastrointestinal conditions. Probiotic traits were notable: surface hydrophobicity (62.9%), auto-aggregation (46.6%), and adhesion to Caco-2 cells (13.24%). Co-aggregation with pathogens was highest for Staphylococcus aureus (52.6%). The strain showed substantial cholesterol assimilation (57.67%), comparable to Lacticaseibacillus rhamnosus GG (59.30%). Antimicrobial assays revealed strong inhibitory activity, particularly against Gram-positive pathogens, with MIC values of 6.25-12.5% (v/v) for acidic cell-free supernatant. Safety assessment confirmed γ-hemolysis, DNase negativity, and a favorable antibiotic susceptibility profile. The results demonstrate that L. helveticus BGRA43 possesses a high potential for application as a functional dairy starter and probiotic, with performance metrics comparable or superior to the established probiotic GG in key properties such as acid tolerance and cholesterol reduction. In the second section of this study, Gaussian Process Regression (GPR) applied to predict bile tolerance and acidity. The GPR model demonstrated high accuracy and robustness, which facilitated the identification of a bacterial strain with promising potential for probiotic applications and industrial process optimization.
Indexed as
Identifiers
42020670What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.